Creyos-preview

Creyos

Private

Toronto, OntarioHealthcare & Life Scienceshttps://creyos.com/

Last Round

Debt

Jul 24, 2023

Total Funding Raised

$2M

Momentum Score

25 /100

Company Overview

Creyos is a healthcare technology company that provides a web-based platform for the assessment of brain health and cognitive function.

Sector

Healthcare & Life Sciences

Verticals

Healthcare Analytics, Mental Health, Clinical Trials

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

cognitive assessment platformneuropsychological testingbehavioral health assessmentbrain health platformcognitive screeningdementia screeningADHD screeningclinical decision supportconcussion assessmentHIPAA-compliant SaaSeCOAcognitive data collectionfitness-for-duty assessmentmental health tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Creyos Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Creyos Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Debt	Jul 24, 2023
Grant	Mar 12, 2021
Growth Equity	Mar 1, 2021

View all Funding Rounds

Key People

Founding team and executive leadership

Risto Juola

Chief Technology Officer

Executive Team

Alex Sherrington

Chief Financial Officer

Executive Team

Faraz Shafaghi

Chief Product Officer

Executive Team

Creyos Investors

Notable investors and investment history

Investor	Rounds
Canada's Digital Technology Supercluster	Grant
Canadian Shield Capital	Growth Equity

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Feb 11, 2026
Attended the 2026 NPA Psychopharmacology Update in Las Vegas.
Sep 30, 2025
Selected as a quarterfinalist for the 2025 Digital Health Awards.

View all signals

Creyos Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Creyos Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Creyos's valuation, stock price, and market status.

Firmographic Details

HeadquartersToronto, Ontario

Employee Range94

Year Founded2015

Last FundingJul 24, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.